scispace - formally typeset
S

S. I. Baithun

Researcher at Royal London Hospital

Publications -  28
Citations -  936

S. I. Baithun is an academic researcher from Royal London Hospital. The author has contributed to research in topics: Transitional cell carcinoma & Urinary bladder. The author has an hindex of 14, co-authored 28 publications receiving 891 citations.

Papers
More filters
Journal ArticleDOI

Morphological study of 391 cases of exocrine pancreatic tumours with special reference to the classification of exocrine pancreatic carcinoma.

TL;DR: Based on the morphology and behaviour of these 391 tumours, the classification of pancreatic carcinoma is discussed and some rare types are compared with previously reported cases and discussed.
Journal ArticleDOI

Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases

TL;DR: Diffuse large B cell lymphoma and MALT-type lymphoma are the most common primary malignant lymphomas of the bladder, and the prognosis of the former is favourable.
Journal ArticleDOI

Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder.

TL;DR: It is concluded that transitional cell carcinomas of the bladder showing squamous metaplasia are mainly resistant to radiotherapy and alternative treatment methods should be sought.
Journal ArticleDOI

Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder

TL;DR: A retrospective analysis of the prognostic value of pretreatment histology and expression of human chorionic gonadotrophin was carried out in 100 invasive transitional cell carcinomas of the bladder treated in a uniform manner, finding that Grade of tumour, necrosis, inflammation, vascular invasion, and growth pattern appeared unrelated to each other or to clinical outcome.
Journal ArticleDOI

Atypical mixed tumor of the skin: histologic, immunohistochemical, and ultrastructural features in three cases and a review of the criteria for malignancy.

TL;DR: The term atypical mixed tumor is recommended for tumors in which there are histological features of malignancy, especially local invasion, without proven metastases, as at present the malignant potential of these tumors cannot be reliably predicted from their histological appearance.